(click on headers to sort columns)

Author(↓)	Class(↓)	Name(↓)	Type(↓)	Date(↓)	Affiliation(↓)
Oaks Z	GENE	TALDO1 (transaldolase 1)	CREATED	2013-07	Departments of Medicine, Microbiology,, Immunology, Biochemistry, Molecular Biology, Neuroscience, Physiology,, Pathology, SUNY Upstate Medical University, Syracuse, New York, USA
Obaya AJ	GENE	ADAMTS12 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif, 12)	CREATED	2013-07	Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006, Asturias, Spain (SC); Biologia Funcional, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006, Asturias, Spain (AJO)
Obaya AJ	GENE	ADAMTS15 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif, 15)	CREATED	2014-02	Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006, Asturias, Spain (SC); Biologia Funcional, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006, Asturias, Spain (AJO)
Obaya AJ	GENE	FBLN2 (fibulin 2)	CREATED	2014-10	Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006, Asturias, Spain (SC); Departamento de Biologia Funcional, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006, Asturias, Spain (AJO)
Oberley M	GENE	E2F6 (E2F transcription factor 6)	CREATED	2004-03	McArdle Laboratory for Cancer Research, University of Wisconsin - Madison, 1400 University Ave. Madison, WI 53706, USA
Ochi K	CASE_REPORT_HEMAT	An adult case of biphenotypic acute leukemia with t(6;14)(q25;q32)	CREATED	2015-09	Department of Hematology/Oncology, Research Hospital (KT, OM, TT, TR, OK, YK, FT, ON, UK, TA); Division of Cell Therapy, Advanced Clinical Research Center (TF); Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, the University of Tokyo (TA), 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Toyotaka Kawamata: toyotaka@ims.u-tokyo.ac.jp, Miho Ogawa: miho.ogawa327@gmail.com; Tomomi Takei: t-takei@ims.u-tokyo.ac.jp; Reina Takeda: reina.takeda@gmail.com; Kiyosumi Ochi: equuleus2015@gmail.com; Kazuaki Yokoyama: k-yoko@ims.u-tokyo.ac.jp; Tomofusa Fukuyama: tfukuyam@ims.u-tokyo.ac.jp; Nobuhiro Ohno: nobuohno@ims.u-tokyo.ac.jp; Kaoru Uchimaru: uchimaru@ims.u-tokyo.ac.jp; Arinobu Tojo: a-tojo@ims.u-tokyo.ac.jp
O'Connor R	GENE	FOXO1 (Forkhead box O1)	CREATED	2008-05	Department of Pathology, Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
Odero MD	CHROM_CLIN	t(5;12)(q31;p13) ETV6/ACSL6 in MDS,AML and AEL	CREATED	2007-03	Departamento de Genetica, Facultades de Ciencias y Medicina, y Area de Oncologia, Centro de Investigacion Medica Aplicada (CIMA), Universidad de Navarra, 31008-Pamplona, Espana
Odero MD	CHROM_CLIN	t(6;12)(p21;p13) CCND3/ETV6 in lymphoid malignancies	CREATED	2006-08	Departamento de Genética, Facultad de Ciencias Àrea de Oncología, Centro de Investigaciò_n Médica Aplicada (CIMA) Universidad de Navarra, 31008 Pamplona, España
Odero MD	CHROM_CLIN	t(12;18)(p13;q12) ETV6/SETBP1	CREATED	2012-03	Division of Oncology, CIMA, University of Navarra, E-31008 Pamplona, Spain (IC, LGO, MDO); Department of Genetics, School of Sciences, University of Navarra, E-31008 Pamplona, Spain (IC, PA, MJC, MDO)
Odero MD	GENE	SETBP1 (SET binding protein 1)	CREATED	2012-09	Translational Oncology Division, Health Research Institute, Oncology Department, University Hospital Fundacion Jimenez Diaz, Autonomous University of Madrid, E-28040 Madrid, Spain (IC); Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, E-31008 Pamplona, Spain (LGO, MDO); Department of Genetics, School of Sciences, University of Navarra E-31008 Pamplona, Spain (MDO)
O'Donovan DS	GENE	SFRP2 (secreted frizzled-related protein 2)	CREATED	2013-08	Prostate Molecular Oncology, Institute of Molecular Medicine, Trinity College, Dublin, Ireland
Ogawa M	CASE_REPORT_HEMAT	An adult case of biphenotypic acute leukemia with t(6;14)(q25;q32)	CREATED	2015-09	Department of Hematology/Oncology, Research Hospital (KT, OM, TT, TR, OK, YK, FT, ON, UK, TA); Division of Cell Therapy, Advanced Clinical Research Center (TF); Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, the University of Tokyo (TA), 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Toyotaka Kawamata: toyotaka@ims.u-tokyo.ac.jp, Miho Ogawa: miho.ogawa327@gmail.com; Tomomi Takei: t-takei@ims.u-tokyo.ac.jp; Reina Takeda: reina.takeda@gmail.com; Kiyosumi Ochi: equuleus2015@gmail.com; Kazuaki Yokoyama: k-yoko@ims.u-tokyo.ac.jp; Tomofusa Fukuyama: tfukuyam@ims.u-tokyo.ac.jp; Nobuhiro Ohno: nobuohno@ims.u-tokyo.ac.jp; Kaoru Uchimaru: uchimaru@ims.u-tokyo.ac.jp; Arinobu Tojo: a-tojo@ims.u-tokyo.ac.jp
Ogita H	GENE	ACTN4 (actinin, alpha 4)	CREATED	2013-04	Department of Biochemistry, Molecular Biology, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga 520-2192, Japan
Ohgami RS	CHROM_CLIN	del (5q) solely in Myelodysplastic syndrome	CREATED	2016-10	Department of Pathology, Stanford University, Stanford, CA, USA; ROhgami@stanfordhealthcare.org
Ohgami R S	CHROM_CLIN	Follicular Dendritic Cell Sarcoma	CREATED	2016-11	Department of Pathology, Stanford University, Stanford, CA, USA; ROhgami@stanfordhealthcare.org
Ohgami RS	CHROM_CLIN	Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)	CREATED	2016-10	Department of Pathology, Stanford University, Stanford, CA, USA; ROhgami@stanfordhealthcare.org
Ohgami RS	CHROM_CLIN	Pediatric-type Follicular Lymphoma	CREATED	2016-05	Department of Pathology, Stanford University, Stanford, CA, USA. ROhgami@stanfordhealthcare.org
Ohno N	CASE_REPORT_HEMAT	An adult case of biphenotypic acute leukemia with t(6;14)(q25;q32)	CREATED	2015-09	Department of Hematology/Oncology, Research Hospital (KT, OM, TT, TR, OK, YK, FT, ON, UK, TA); Division of Cell Therapy, Advanced Clinical Research Center (TF); Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, the University of Tokyo (TA), 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Toyotaka Kawamata: toyotaka@ims.u-tokyo.ac.jp, Miho Ogawa: miho.ogawa327@gmail.com; Tomomi Takei: t-takei@ims.u-tokyo.ac.jp; Reina Takeda: reina.takeda@gmail.com; Kiyosumi Ochi: equuleus2015@gmail.com; Kazuaki Yokoyama: k-yoko@ims.u-tokyo.ac.jp; Tomofusa Fukuyama: tfukuyam@ims.u-tokyo.ac.jp; Nobuhiro Ohno: nobuohno@ims.u-tokyo.ac.jp; Kaoru Uchimaru: uchimaru@ims.u-tokyo.ac.jp; Arinobu Tojo: a-tojo@ims.u-tokyo.ac.jp
Ohnuma K	GENE	DPP4 (dipeptidyl-peptidase 4)	CREATED	2012-11	Department of Therapy Development, Innovation for Immune disorders, Cancers, Graduate School of Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
Okamoto K	GENE	RIOX2 (ribosomal oxygenase 2)	CREATED	2010-04	Laboratory of Molecular, Cellular Biology, Department of Molecular Pharmacology, Faculty of Pharmacy, Takasaki University of Health, Welfare, 60 Nakaorui-machi, Takasaki-shi, Gunma 370-0033, Japan
Okkeri J	GENE	KIAA1524	CREATED	2010-01	Centre for Biotechnology, University of Turku, Abo Akademi, Tykistokatu 6A, 20520 Turku, Finland (JO, JW); Institute of Medical Technology, University of Tampere, Biokatu 6-8, 33520 Tampere, Finland (AK)
Olalla Saad ST	GENE	ARHGAP21 (Rho GTPase activating protein 21)	CREATED	2016-12	Hematology and Blood Transfusion Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas (MFP, STOS, ML); Department of Biological Sciences, Federal University of São Paulo, Diadema (ML), Brazil. lazarini@unifesp.br; marilazarini@gmail.com
Olazabal-Herrero A	GENE	WDR48 (WD repeat domain 48)	CREATED	2017-04	Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (UPV/EHU), Leioa, Spain; ane.olazabal@ehu.eus; josean.rodriguez@ehu.eus (AOH, JAR); Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands; gj.peters@vumc.nl; elisa.giovannetti@gmail.com (GJP, EG); Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa , Italy (EG).
Oliva J	GENE	UBD (ubiquitin D)	CREATED	2011-11	Department of Hematology, LA Biomed, Torrance, CA 90502, USA (JA); Department of Pathology, LA BioMed, Torrance, CA 90502, USA (SWF)
Oliveira AM	GENE	USP6 (ubiquitin specific protease 6 (Tre-2 oncogene))	CREATED	2005-04	Department of Pathology, Laboratory Medicine, Mayo Clinic, Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
Oliveira DT	GENE	ADRB2 (adrenoceptor beta 2, surface)	CREATED	2014-02	Department of Stomatology, Area of Pathology, Bauru School of Dentistry - University of Sao Paulo, Bauru, Brazil
Olivieri C	GENE	ACVRL1 (activin A receptor type II-like 1)	CREATED	2014-03	Dept of Molecular Medicine, Unit of General Biology, Medical Genetics, University of Pavia, Italy (FO, SP, CO); Dept of Molecular Medicine, Unit of Immunology, General Pathology, University of Pavia, Italy (LV, CS)
Olivier M	GENE	TP53 (Tumour protein p53 (Li-Fraumeni syndrome))	UPDATED	2007-04	Molecular Carcinogenesis, Biomarkers Group, International Agency for Research on Cancer (IARC/CIRC), 150 Cours Albert Thomas, F-69372 Lyon CEDEX 08, France
Oliviero S	GENE	VEGFD (c-fos induced growth factor (vascular endothelial growth factor D))	CREATED	2012-05	Department of Molecular Biology, University of Siena, Italy
O'Loghlen A	GENE	CBX7 (chromobox homolog 7)	CREATED	2011-11	Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London W12 0NN, UK
Olschwang S	K_PRONE	Familial adenomatous polyposis (FAP)	CREATED	1998-06	INSERM U434, Fondation Jean Dausset - C.E.P.H., 27, rue Juliette Dodu, 75010 Paris, France
Omabe M	DEEP_INSIGHT	Insight in inflammation and cancer	CREATED	2013-10	Molecular Cancer Biology Research Group, Molecular Pathology, Immunology Division, Department of Medical Laboratory Sciences, School of Biomedical Science, Faculty of Health Science, Ebonyi State University Nigeria (MO); Department of cancer studies, Molecular medicine, University of Leicester, United Kingdom (NOK)
O'Neill AK	GENE	PHLPP1 (PH domain leucine-rich repeat protein phosphatase 1)	CREATED	2009-06	Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., 0721, La Jolla, CA 92093, USA
O'Neill AK	GENE	PHLPP2 (PH domain leucine-rich repeat protein phosphatase 2)	CREATED	2009-06	Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., Mail Code 0721, La Jolla, CA 92093, USA
Onodera Y	GENE	ASAP1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain 1)	CREATED	2012-02	Hokkaido University Graduate School of Medicine, Department of Molecular Biology, Sapporo, Japan
Orlandini M	GENE	DAB2 (disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila))	CREATED	2009-05	Department of Molecular Biology, Via Fiorentina 1, 53100 - Siena, Italy
Ornati F	GENE	ACVRL1 (activin A receptor type II-like 1)	CREATED	2014-03	Dept of Molecular Medicine, Unit of General Biology, Medical Genetics, University of Pavia, Italy (FO, SP, CO); Dept of Molecular Medicine, Unit of Immunology, General Pathology, University of Pavia, Italy (LV, CS)
Orso F	GENE	TFAP2A (transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha))	CREATED	2009-09	Molecular Biotechnology Center (MBC), Department of Oncological Sciences, University of Torino, Via Nizza, 52, 10126 Torino, Italy (FO, DT); Center for Complex Systems in Molecular Biology, Medicine, University of Torino, Via Acc Albertina, 13, 10023 Torino, Italy (FO, DT)
Ostrowski J	GENE	HNRNPK (heterogeneous nuclear ribonucleoprotein K)	CREATED	2009-03	Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology Warsaw, Poland
Ottaviani A	DEEP_INSIGHT	Dynamics and plasticity of chromosome ends: consequences in human pathologies	CREATED	2009-06	Laboratoire de Biologie Moléculaire de la Cellule, CNRS UMR5239, Ecole Normale Supérieure de Lyon, UCBL1, IFR128. 46 allée d'Italie, 69364 Lyon Cedex 07, France
Ouadid-Ahidouch H	GENE	ORAI3 (ORAI calcium release-activated calcium modulator 3)	CREATED	2014-06	University of Picardie Jules Verne, UFR Sciences, EA 4667, Laboratory of Cell, Molecular Physiology, SFR CAP-SANTE (FED 4231), Amiens, France (JH, NB, MF, ASA, PK, FH, HS, AA, HOA); University of Picardie Jules Verne, Amiens University Hospital, Department of Pathology, Tumor Bank of Picardie, Amiens, France (NB, HS); Department of Biology, Faculty of Sciences, University Ibn Zohr, Agadir, Morocco (AA)
Ouahchi K	CASE_REPORT_HEMAT	t(16;21)(q24;q22) in therapy-related acute myelogenous leukemia arising from myelodysplastic syndrome	CREATED	2007-02	Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA
Ouban A	DEEP_INSIGHT	The Claudins family: Structure and function in normal and pathologic conditions	CREATED	2012-07	Department of Pathology, College of Medicine, Prince Salman University, Kharj, Kingdom of Saudi Arabia (AO); Department of Pathology, Children's Mercy Hospital, University of Kansas, Kansas City, Missouri, USA (AAA)
Ouchida M	GENE	SS18 (synovial sarcoma translocation, chromosome 18)	CREATED	2006-05	Department of Molecular Genetics, Graduate School of Medicine, Dentistry, Pharmaceutical Sciences, Okayama University. Shikata-cho 2-5-1, Okayama 700-8558, Japan
Ouertani A	GENE	PFKFB4 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4)	CREATED	2013-04	German Cancer Research Center (DKFZ), Department of Molecular Genetics, Heidelberg, Germany
Ou SH	GENE	ROS1 (ROS proto-oncogene 1 , receptor tyrosine kinase)	CREATED	2014-01	University of California Irvine Medical Center, Orange, CA. sklempne@uci.edu; siou@uci.edu
Ouwens DM	GENE	AKT1S1 (AKT1 substrate 1 (proline-rich))	CREATED	2014-11	German Diabetes Centre, Institute for Clinical Biochemistry, Pathobiochemistry, Duesseldorf, Germany (CW, DMO); German Centre for Diabetes Research (DZD e.V.), Partner Duesseldorf, Germany (CW, DMO); Department of Human Biology, Maastricht University Medical Center, Maastricht, The Netherlands (EBMN); Department of Endocrinology, Ghent University Hospital, Ghent, Belgium (DMO); Department of Internal Medicine, division 1, University Hospital Cologne, Cologne, Germany (CW)
Ovechkina V	CASE_REPORT_HEMAT	t(6;8)(q27;p12) in a new case "8p11 myeloproliferative syndrome"	CREATED	2011-11	I.P.Pavlov State Medical University, R.M. Gorbacheva Memorial Institute of Children Hematology and Transplantation, Cytogenetic Laboratory, Saint Petersburg, Russia
Ovechkina V	CASE_REPORT_HEMAT	A new case of Acute Myeloid Leukemia with semi-cryptic t(7;21)(p22;q22)	CREATED	2012-04	I.P. Pavlov State Medical University, R.M. Gorbacheva Memorial Institute of Children Hematology and Transplantation, Cytogenetic Laboratory, Saint Petersburg, Russia (TG, IB, MV, EN, IP, VO, TS); City Children's Hospital No.1, Saint Petersburg, Russia (EB, IG)
Owen H	GENE	MBD2 (methyl CpG binding domain protein 2)	CREATED	2009-10	Wellcome Trust Centre for Cell Biology, University of Edinburgh, Michael Swann Building, King's Buildings, Mayfield Road, Edinburgh EH9 3JR, UK
Owen LA	GENE	NKX2-2 (NK2 homeobox 2)	CREATED	2008-01	Department of Oncological Sciences, University of Utah School of Medicine, Center for Children, Huntsman Cancer Institute,, Division of Pediatric Hematology/Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA
Oyken M	GENE	ALCAM (Activated Leukocyte Cell Adhesion Molecule)	CREATED	2017-06	Esra Yavuz: Department of Biological Sciences, Middle East Technical University, Ankara, Turkey, yavuzesra3@gmail.com; oyken.merve@metu.edu.tr; erson@metu.edu.tr
Ozawa MG	CHROM_CLIN	Pediatric-type Follicular Lymphoma	CREATED	2016-05	Department of Pathology, Stanford University, Stanford, CA, USA. ROhgami@stanfordhealthcare.org
Ozkayar O	GENE	EEF2K (eukaryotic elongation factor 2 kinase)	CREATED	2016-01	University of Texas-Houston-MD Anderson Cancer Center, Department of Experimental Therapeutics, 1515 Holcombe Boulevard, Unit 422, Houston, TX7730; Bozpolat@mdanderson.org
Ozpolat B	GENE	EEF2K (eukaryotic elongation factor 2 kinase)	CREATED	2016-01	University of Texas-Houston-MD Anderson Cancer Center, Department of Experimental Therapeutics, 1515 Holcombe Boulevard, Unit 422, Houston, TX7730; Bozpolat@mdanderson.org